Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
The RSV shot — the first ever drug using mRNA technology approved for a disease other than COVID — gives it another ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid ...
Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer PFE-N and BioNTech ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...